Post-trial obligations - DOI: 10.3395/reciis.v2.Sup1.210en
In its essence, post-trial obligations describe a duty by research sponsors to provide a successfully tested drug to research participants who took part in the relevant clinical trials after the trial has been concluded. In some instances, this duty is extended beyond the research participants. This...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Icict) da Fundação Oswaldo Cruz (Fiocruz)
2008-12-01
|
Series: | RECIIS |
Subjects: | |
Online Access: | http://www.reciis.cict.fiocruz.br/index.php/reciis/article/view/210/188 |